SG11201507482UA - Methods for treating psoriasis using an anti-il-23 antibody - Google Patents
Methods for treating psoriasis using an anti-il-23 antibodyInfo
- Publication number
- SG11201507482UA SG11201507482UA SG11201507482UA SG11201507482UA SG11201507482UA SG 11201507482U A SG11201507482U A SG 11201507482UA SG 11201507482U A SG11201507482U A SG 11201507482UA SG 11201507482U A SG11201507482U A SG 11201507482UA SG 11201507482U A SG11201507482U A SG 11201507482UA
- Authority
- SG
- Singapore
- Prior art keywords
- antibody
- methods
- treating psoriasis
- psoriasis
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789777P | 2013-03-15 | 2013-03-15 | |
| PCT/US2014/018293 WO2014149425A1 (en) | 2013-03-15 | 2014-02-25 | Methods for treating psoriasis using an anti-il-23 antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201507482UA true SG11201507482UA (en) | 2015-10-29 |
Family
ID=50336511
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201507482UA SG11201507482UA (en) | 2013-03-15 | 2014-02-25 | Methods for treating psoriasis using an anti-il-23 antibody |
| SG10201804954UA SG10201804954UA (en) | 2013-03-15 | 2014-02-25 | Methods for treating psoriasis using an anti-il-23 antibody |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201804954UA SG10201804954UA (en) | 2013-03-15 | 2014-02-25 | Methods for treating psoriasis using an anti-il-23 antibody |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20160060337A1 (https=) |
| EP (2) | EP3689369A1 (https=) |
| JP (4) | JP2016517408A (https=) |
| KR (1) | KR20150128858A (https=) |
| CN (1) | CN105209064A (https=) |
| AP (1) | AP2015008803A0 (https=) |
| AU (3) | AU2014238148A1 (https=) |
| CA (1) | CA2906382A1 (https=) |
| CL (1) | CL2015002723A1 (https=) |
| CR (1) | CR20150572A (https=) |
| EA (1) | EA201591581A1 (https=) |
| HK (1) | HK1219425A1 (https=) |
| IL (2) | IL241342A0 (https=) |
| PH (2) | PH12015502129A1 (https=) |
| SG (2) | SG11201507482UA (https=) |
| TN (1) | TN2015000403A1 (https=) |
| WO (1) | WO2014149425A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019000046A (es) | 2010-11-04 | 2023-10-05 | Boehringer Ingelheim Int | Anticuerpos anti-il-23. |
| PL3326649T3 (pl) | 2012-05-03 | 2022-04-25 | Boehringer Ingelheim International Gmbh | Przeciwciała anty-il-23p19 |
| EP3708679A1 (en) | 2014-07-24 | 2020-09-16 | Boehringer Ingelheim International GmbH | Biomarkers useful in the treatment of il-23a related diseases |
| EA202193002A2 (ru) | 2014-09-03 | 2022-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Соединение, нацеленное на ил-23a и фно-альфа, и его применение |
| AU2016215535B2 (en) * | 2015-02-04 | 2021-09-16 | Boehringer Ingelheim International Gmbh | Methods of treating inflammatory diseases |
| CN109071653A (zh) * | 2016-03-29 | 2018-12-21 | 詹森生物科技公司 | 用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣 |
| JP6728392B2 (ja) * | 2016-04-15 | 2020-07-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 炎症性疾患の処置法 |
| US20200025776A1 (en) * | 2018-07-18 | 2020-01-23 | Janssen Biotech, Inc. | Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody |
| CA3118964A1 (en) * | 2018-11-05 | 2020-05-14 | Merck Sharp & Dohme Corp. | Dosing regimen of anti-tigit antibody for treatment of cancer |
| JP2022526493A (ja) * | 2019-03-18 | 2022-05-25 | ヤンセン バイオテツク，インコーポレーテツド | 抗ｉｌ１２／ｉｌ２３抗体を用いた小児被験者の乾癬の治療方法 |
| TW202535466A (zh) | 2019-09-09 | 2025-09-16 | 德商百靈佳殷格翰國際股份有限公司 | 抗-il-23p19抗體調配物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| ZA986596B (en) | 1997-07-25 | 1999-02-08 | Schering Corp | Mammalian cytokine related reagents |
| SI2452694T1 (sl) | 2005-06-30 | 2019-05-31 | Janssen Biotech, Inc. | Protitelesa proti-IL-23, sestavki in postopki uporabe |
| DE602006015830D1 (de) | 2005-08-25 | 2010-09-09 | Lilly Co Eli | Anti-il-23-antikörper |
| US20070050011A1 (en) | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
| PT1931710T (pt) | 2005-08-31 | 2017-03-28 | Merck Sharp & Dohme | Anticorpos anti-il-23 manipulados |
| CN101389769A (zh) * | 2005-12-28 | 2009-03-18 | 森托科尔公司 | 用于评价和治疗银屑病及相关疾病的标记与方法 |
| HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-IL-23 antibodies, preparations, methods and applications |
| US7790862B2 (en) | 2006-06-13 | 2010-09-07 | Zymogenetics, Inc. | IL-17 and IL-23 antagonists and methods of using the same |
| JP2010518858A (ja) | 2007-02-23 | 2010-06-03 | シェーリング コーポレイション | 操作された抗−ｉｌ−２３ｐ１９抗体 |
| ES2708988T3 (es) | 2007-02-23 | 2019-04-12 | Merck Sharp & Dohme | Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| WO2009117289A2 (en) * | 2008-03-18 | 2009-09-24 | Abbott Laboratories | Methods for treating psoriasis |
| EP2301119B1 (en) | 2008-06-30 | 2015-05-13 | Black & Decker, Inc. | Cord protector for power tools |
| EP2331078B1 (en) | 2008-08-27 | 2012-09-19 | Merck Sharp & Dohme Corp. | Lyophilized formulations of engineered anti-il-23p19 antibodies |
| US20120128689A1 (en) | 2009-04-01 | 2012-05-24 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| US20120264917A1 (en) | 2009-05-27 | 2012-10-18 | Ablynx N.V. | Biparatopic protein constructs directed against il-23 |
| SG179135A1 (en) * | 2009-09-14 | 2012-05-30 | Abbott Lab | Methods for treating psoriasis |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| WO2012009760A1 (en) | 2010-07-20 | 2012-01-26 | Cephalon Australia Pty Ltd | Anti-il-23 heterodimer specific antibodies |
| CN103813804A (zh) * | 2010-10-06 | 2014-05-21 | Abbvie公司 | 用于治疗银屑病的方法 |
| CN103154031A (zh) * | 2010-10-08 | 2013-06-12 | 诺华有限公司 | 利用il-17拮抗剂治疗牛皮癣的方法 |
| MX2019000046A (es) | 2010-11-04 | 2023-10-05 | Boehringer Ingelheim Int | Anticuerpos anti-il-23. |
-
2014
- 2014-02-25 SG SG11201507482UA patent/SG11201507482UA/en unknown
- 2014-02-25 CN CN201480015797.0A patent/CN105209064A/zh active Pending
- 2014-02-25 EA EA201591581A patent/EA201591581A1/ru unknown
- 2014-02-25 SG SG10201804954UA patent/SG10201804954UA/en unknown
- 2014-02-25 HK HK16107479.7A patent/HK1219425A1/zh unknown
- 2014-02-25 AU AU2014238148A patent/AU2014238148A1/en not_active Abandoned
- 2014-02-25 EP EP19206477.2A patent/EP3689369A1/en not_active Withdrawn
- 2014-02-25 CA CA2906382A patent/CA2906382A1/en not_active Abandoned
- 2014-02-25 WO PCT/US2014/018293 patent/WO2014149425A1/en not_active Ceased
- 2014-02-25 JP JP2016500381A patent/JP2016517408A/ja active Pending
- 2014-02-25 US US14/776,222 patent/US20160060337A1/en not_active Abandoned
- 2014-02-25 EP EP14711352.6A patent/EP2968488A1/en not_active Withdrawn
- 2014-02-25 KR KR1020157027833A patent/KR20150128858A/ko not_active Ceased
- 2014-02-25 AP AP2015008803A patent/AP2015008803A0/xx unknown
-
2015
- 2015-09-09 IL IL241342A patent/IL241342A0/en unknown
- 2015-09-09 TN TN2015000403A patent/TN2015000403A1/en unknown
- 2015-09-15 CL CL2015002723A patent/CL2015002723A1/es unknown
- 2015-09-15 PH PH12015502129A patent/PH12015502129A1/en unknown
- 2015-10-15 CR CR20150572A patent/CR20150572A/es unknown
-
2019
- 2019-01-11 AU AU2019200206A patent/AU2019200206A1/en not_active Abandoned
- 2019-09-24 JP JP2019172758A patent/JP2020063237A/ja active Pending
- 2019-10-10 US US16/598,714 patent/US20200277368A1/en not_active Abandoned
- 2019-11-28 PH PH12019502700A patent/PH12019502700A1/en unknown
-
2020
- 2020-06-03 IL IL275093A patent/IL275093A/en unknown
- 2020-11-18 AU AU2020270495A patent/AU2020270495A1/en not_active Abandoned
-
2021
- 2021-03-29 JP JP2021054632A patent/JP2021102644A/ja active Pending
-
2022
- 2022-01-13 US US17/574,980 patent/US20220135668A1/en not_active Abandoned
- 2022-11-02 JP JP2022175999A patent/JP2023011815A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CL2015002723A1 (es) | 2016-03-28 |
| HK1219425A1 (zh) | 2017-04-07 |
| PH12019502700A1 (en) | 2020-12-07 |
| CN105209064A (zh) | 2015-12-30 |
| AU2014238148A1 (en) | 2015-10-08 |
| IL241342A0 (en) | 2015-11-30 |
| AP2015008803A0 (en) | 2015-10-31 |
| CA2906382A1 (en) | 2014-09-25 |
| EP2968488A1 (en) | 2016-01-20 |
| AU2019200206A1 (en) | 2019-01-31 |
| JP2023011815A (ja) | 2023-01-24 |
| JP2016517408A (ja) | 2016-06-16 |
| US20160060337A1 (en) | 2016-03-03 |
| CR20150572A (es) | 2016-04-25 |
| SG10201804954UA (en) | 2018-07-30 |
| US20200277368A1 (en) | 2020-09-03 |
| TN2015000403A1 (en) | 2017-01-03 |
| JP2021102644A (ja) | 2021-07-15 |
| EA201591581A1 (ru) | 2016-01-29 |
| AU2020270495A1 (en) | 2020-12-17 |
| US20220135668A1 (en) | 2022-05-05 |
| JP2020063237A (ja) | 2020-04-23 |
| KR20150128858A (ko) | 2015-11-18 |
| EP3689369A1 (en) | 2020-08-05 |
| PH12015502129A1 (en) | 2016-01-25 |
| IL275093A (en) | 2020-07-30 |
| WO2014149425A1 (en) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL292193A (en) | Anti-b7–h1 antibodies for the treatment of tumors | |
| IL275093A (en) | Methods for the treatment of eczema using an anti-IL-23 antibody | |
| IL287915A (en) | Methods for treating brittle bones | |
| LT3076949T (lt) | Iš vėžinių ląstelių kilusių egzosomų išskyrimo būdas | |
| GB201306607D0 (en) | Method for treating an animal substrate | |
| IL242695B (en) | Device for the production of molybdenum-99 | |
| PT3004163T (pt) | Método para purificação de anticorpo | |
| PL2983787T3 (pl) | Sposób leczenia zespołu stresu pourazowego | |
| SG11201603050TA (en) | Methods for treating cancers | |
| GB201318983D0 (en) | Radiotherapy apparatus | |
| ZA201505856B (en) | Method for producing acrylic acid | |
| GB201315777D0 (en) | Novel method | |
| IL239689A0 (en) | A method for producing antibodies | |
| GB201412190D0 (en) | Method of optimization for an application | |
| ZA201506725B (en) | Method for producing leather | |
| EP2952895A4 (en) | PROCESS FOR PRODUCING A MARKED ANTIBODY | |
| PL3043814T3 (pl) | Antygen i sposób jego wytwarzania | |
| PL3071969T3 (pl) | Sposób analizy | |
| EP3082841A4 (en) | Methods for treating an animal | |
| HUE048625T2 (hu) | Módszer rák kezelésére | |
| IL241779A0 (en) | Method for protein production | |
| ZA201507507B (en) | Method for scheduling ovulation | |
| GB201310151D0 (en) | Novel method | |
| GB201301384D0 (en) | Method for antibody production | |
| GB201303520D0 (en) | Biomass process optimisation |